or Try an Advanced Search...

    Technical Analysis for SGMT - Sagimet Biosciences Inc.

    Grade Last Price % Change Price Change
    F 4.62 5.48% 0.24
    SGMT closed up 5.48 percent on Wednesday, May 15, 2024, on 57 percent of normal volume. It ran into resistance at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical SGMT trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Bollinger Band Squeeze Range Contraction 5.48%
    Inside Day Range Contraction 5.48%
    Gapped Up Strength 5.48%
    Bollinger Band Squeeze Range Contraction 8.96%
    BB Squeeze + Upper Band Touch Range Contraction 8.96%
    Gapped Up Strength 8.96%
    Older End-of-Day Signals for SGMT ...

       Recent Intraday Alerts

    Alert Time
    Upper Bollinger Band Resistance about 14 hours ago
    50 DMA Resistance about 15 hours ago
    Up 10% about 15 hours ago
    Up 1 ATR about 15 hours ago
    Rose Above 50 DMA about 15 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SGMT Chart by TradingView
    Basic chart:

    Profile

    Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne

    Is SGMT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    May 7 Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 Study of Denifanstat in MASH at EASL International Liver Congress 2024
    May 6 Sagimet Biosciences gets new finance head
    May 6 Sagimet Biosciences Announces Appointment of Thierry Chauche as Chief Financial Officer
    Apr 26 Sagimet Biosciences' Denifanstat Imminent Phase 3: A Promising Investment Opportunity
    Apr 22 Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024
    Mar 27 Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat
    Mar 25 Sagimet stock jumps 23% in wake of Q4 report, business updates
    Mar 25 Sagimet Biosciences GAAP EPS of -$2.66 beats by $34.65, revenue of $2M in-line
    Mar 25 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
    See more SGMT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.71
    52 Week Low 2.13
    Average Volume 722,680
    200-Day Moving Average 7.13
    50-Day Moving Average 4.72
    20-Day Moving Average 4.24
    10-Day Moving Average 4.41
    Average True Range 0.40
    RSI (14) 52.38
    ADX 12.67
    +DI 24.08
    -DI 15.63
    Chandelier Exit (Long, 3 ATRs) 3.74
    Chandelier Exit (Short, 3 ATRs) 5.04
    Upper Bollinger Bands 4.65
    Lower Bollinger Band 3.82
    Percent B (%b) 0.96
    BandWidth 19.54
    MACD Line -0.11
    MACD Signal Line -0.19
    MACD Histogram 0.0859
    Fundamentals Value
    Market Cap 140.33 Million
    Num Shares 30.4 Million
    EPS -1.18
    Price-to-Earnings (P/E) Ratio -3.92
    Price-to-Sales 99.52
    Price-to-Book 1.96
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.27
    Resistance 3 (R3) 5.27 5.05 5.16
    Resistance 2 (R2) 5.05 4.89 5.05 5.12
    Resistance 1 (R1) 4.84 4.79 4.95 4.84 5.09
    Pivot Point 4.62 4.62 4.68 4.62 4.62
    Support 1 (S1) 4.41 4.46 4.52 4.41 4.15
    Support 2 (S2) 4.19 4.36 4.19 4.12
    Support 3 (S3) 3.98 4.19 4.08
    Support 4 (S4) 3.98